Chardan Capital Reaffirms “Neutral” Rating for Allurion Technologies (NYSE:ALUR)

Chardan Capital reissued their neutral rating on shares of Allurion Technologies (NYSE:ALURFree Report) in a research note released on Friday,Benzinga reports. Chardan Capital currently has a $2.50 price objective on the stock.

Allurion Technologies Trading Up 57.7 %

Allurion Technologies stock opened at $3.60 on Friday. Allurion Technologies has a 1 year low of $2.15 and a 1 year high of $98.75. The company’s 50-day moving average is $4.00 and its two-hundred day moving average is $10.19. The company has a market cap of $17.24 million, a PE ratio of -0.30 and a beta of -0.59.

Institutional Trading of Allurion Technologies

A hedge fund recently raised its stake in Allurion Technologies stock. Geode Capital Management LLC increased its stake in shares of Allurion Technologies Inc. (NYSE:ALURFree Report) by 40.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 516,330 shares of the company’s stock after purchasing an additional 149,484 shares during the period. Geode Capital Management LLC owned approximately 0.80% of Allurion Technologies worth $317,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 21.39% of the company’s stock.

Allurion Technologies Company Profile

(Get Free Report)

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.

See Also

Receive News & Ratings for Allurion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allurion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.